Roth Capital Estimates FIGS’s Q1 Earnings (NYSE:FIGS)

FIGS, Inc. (NYSE:FIGS) – Analysts at Roth Capital issued their Q1 2025 earnings per share estimates for shares of FIGS in a report issued on Friday, February 28th. Roth Capital analyst M. Koranda expects that the company will post earnings of ($0.01) per share for the quarter. The consensus estimate for FIGS’s current full-year earnings is $0.01 per share. Roth Capital also issued estimates for FIGS’s Q3 2025 earnings at $0.00 EPS, Q4 2025 earnings at $0.03 EPS, FY2025 earnings at $0.04 EPS and FY2026 earnings at $0.15 EPS.

A number of other equities analysts have also recently commented on the stock. Telsey Advisory Group reissued a “market perform” rating and issued a $7.00 price objective on shares of FIGS in a research note on Friday. Barclays dropped their price target on shares of FIGS from $5.00 to $4.00 and set an “equal weight” rating for the company in a research note on Tuesday, November 12th. Finally, The Goldman Sachs Group decreased their price objective on shares of FIGS from $5.00 to $4.50 and set a “sell” rating for the company in a research note on Tuesday, December 10th. Two analysts have rated the stock with a sell rating, three have issued a hold rating and one has given a buy rating to the company. Based on data from MarketBeat.com, the company currently has an average rating of “Hold” and a consensus price target of $5.35.

FIGS Stock Performance

FIGS stock opened at $4.60 on Monday. The firm has a fifty day moving average price of $5.69 and a 200 day moving average price of $5.77. FIGS has a fifty-two week low of $4.30 and a fifty-two week high of $7.05. The firm has a market cap of $781.13 million, a PE ratio of 76.67, a price-to-earnings-growth ratio of 31.62 and a beta of 1.22.

Insider Buying and Selling

In other news, insider Heather L. Hasson sold 26,855 shares of the business’s stock in a transaction dated Monday, January 6th. The shares were sold at an average price of $5.96, for a total value of $160,055.80. Following the completion of the sale, the insider now owns 354,221 shares in the company, valued at approximately $2,111,157.16. The trade was a 7.05 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. 22.30% of the stock is owned by insiders.

Hedge Funds Weigh In On FIGS

Several institutional investors have recently bought and sold shares of FIGS. Creative Planning increased its holdings in shares of FIGS by 17.7% in the 3rd quarter. Creative Planning now owns 12,697 shares of the company’s stock valued at $87,000 after acquiring an additional 1,911 shares during the period. International Assets Investment Management LLC boosted its position in FIGS by 787.0% during the third quarter. International Assets Investment Management LLC now owns 13,926 shares of the company’s stock valued at $950,000 after purchasing an additional 12,356 shares in the last quarter. Malaga Cove Capital LLC grew its stake in FIGS by 18.4% in the third quarter. Malaga Cove Capital LLC now owns 214,122 shares of the company’s stock valued at $1,465,000 after purchasing an additional 33,278 shares during the last quarter. GSA Capital Partners LLP bought a new position in FIGS in the third quarter worth about $104,000. Finally, Aigen Investment Management LP boosted its holdings in shares of FIGS by 40.3% in the 3rd quarter. Aigen Investment Management LP now owns 22,840 shares of the company’s stock valued at $156,000 after buying an additional 6,562 shares in the last quarter. 92.21% of the stock is owned by hedge funds and other institutional investors.

FIGS Company Profile

FIGS, Inc operates as a direct-to-consumer healthcare apparel and lifestyle company in the United States and internationally. It designs and sells healthcare apparel and scrubwear and non-scrubwear offerings, such as outerwear, underscrubs, footwear, compression socks, lab coats, loungewear, and other apparel.